Here’s why we must continue to study Kratom and other opioid-like drugs
The FDA recommendation to the Drug Enforcement Agency (DEA) to schedule (as in, effectively ban) Kratom and its alkaloids threatens fledgling efforts by researchers to investigate the alkaloids as potential new pain treatments, would hinder scientific advances as well as crucial preclinical and clinical studies. In February 2018, the FDA commissioner released a statement declaring…
Recent Comments